Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne E Kavanagh

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Chest|November 8, 2020
ResponseJoanne E Kavanagh, David J Jackson
Pulmonary Pharmacology & Therapeutics|April 2, 2019
Idiopathic pulmonary fibrosis-associated cough: Mechanisms and managementKatherine J Myall, Joanne E Kavanagh, Surinder S Birring
Breathe (Sheffield, England)|March 17, 2022
A pragmatic guide to choosing biologic therapies in severe asthmaJoanne E Kavanagh, Andrew P Hearn, David J Jackson
Chest|July 24, 2018
Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel ReportSurinder S Birring, Joanne E Kavanagh, Richard S Irwin, et al.
Chest|April 11, 2020
Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Grainne d'Ancona, Maria Elstad, et al.
Allergy|January 12, 2021
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthmaGrainne d'Ancona, Joanne E Kavanagh, Jaideep Dhariwal, et al.
Allergy|December 10, 2020
Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthmaJoanne E Kavanagh, Andrew P Hearn, Grainne d'Ancona, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 10, 2021
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal SensitizationJaideep Dhariwal, Andrew P Hearn, Joanne E Kavanagh, et al.
Chest|September 4, 2020
Real-World Effectiveness of Benralizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Andrew P Hearn, Jaideep Dhariwal, et al.
The European Respiratory Journal|July 20, 2023
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthmaAlexandra M Nanzer, Victoria Taylor, Andrew P Hearn, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chest|November 8, 2020
ResponseJoanne E Kavanagh, David J Jackson
Pulmonary Pharmacology & Therapeutics|April 2, 2019
Idiopathic pulmonary fibrosis-associated cough: Mechanisms and managementKatherine J Myall, Joanne E Kavanagh, Surinder S Birring
Breathe (Sheffield, England)|March 17, 2022
A pragmatic guide to choosing biologic therapies in severe asthmaJoanne E Kavanagh, Andrew P Hearn, David J Jackson
Chest|July 24, 2018
Treatment of Interstitial Lung Disease Associated Cough: CHEST Guideline and Expert Panel ReportSurinder S Birring, Joanne E Kavanagh, Richard S Irwin, et al.
Chest|April 11, 2020
Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Grainne d'Ancona, Maria Elstad, et al.
Allergy|January 12, 2021
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthmaGrainne d'Ancona, Joanne E Kavanagh, Jaideep Dhariwal, et al.
Allergy|December 10, 2020
Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthmaJoanne E Kavanagh, Andrew P Hearn, Grainne d'Ancona, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 10, 2021
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal SensitizationJaideep Dhariwal, Andrew P Hearn, Joanne E Kavanagh, et al.
Chest|September 4, 2020
Real-World Effectiveness of Benralizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Andrew P Hearn, Jaideep Dhariwal, et al.
The European Respiratory Journal|July 20, 2023
The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthmaAlexandra M Nanzer, Victoria Taylor, Andrew P Hearn, et al.
Pageof 1